Perspectives on Oncology Pharmacy in Developing Countries - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

Perspectives on Oncology Pharmacy in Developing Countries

Description:

1995 UICC sponsors first traveling health care team, to examine health care ... Trainees buddied' with junior physician trainee in Pediatric Hematology/Oncology. ... – PowerPoint PPT presentation

Number of Views:581
Avg rating:3.0/5.0
Slides: 19
Provided by: sobra
Category:

less

Transcript and Presenter's Notes

Title: Perspectives on Oncology Pharmacy in Developing Countries


1
Perspectives on Oncology Pharmacy in Developing
Countries
  • John T. Wiernikowski, PharmD
  • 1st Conference of the Brazilian Society of
    Oncology Pharmacists
  • Rio De Janeiro

2
Outline
  • History
  • Models for care delivery
  • Training Programs
  • Opportunities for your Society
  • Internal
  • Guidelines, Standards of Practice
  • External
  • Chapter Status in ISOPP, FIP

3
History
  • 1995 UICC sponsors first traveling health care
    team, to examine health care models and service
    needs for children with cancer.
  • Team composed of Medical and Radiation
    Oncologist, Nurse, Pharmacist, Pathologist.
  • Visited centers in Brazil, Chile, Argentina, and
    Uruguay.

4
Health Care Team Models
Patient and Family
Medical Oncologist
Surgeon
Radiation Oncologist
Pathologist
Nurses
Pharmacists
Physiotherapists
Social Worker
Patient and Family
5
Health Care Team Models
6
Training in Pediatric Oncology Clinical Pharmacy
  • A proposal for South America

7
Background
  • Recommendation of the first UICC (endorsed)
    sponsored traveling team 1995.
  • Other related endeavors
  • MD training programs established (twinning with
    MISPHO).
  • Oncology nursing program developed (UCSF/St.
    Jude).
  • Establishment of a tumour bank, and board of
    reference pathologists.

8
Needs Justification
  • Spectrum of childhood disease changing in
    developing countries, as infectious diseases are
    conquered (cancer assumes increasing importance).
  • Care of oncology patients increasing in
    complexity.
  • Recognized need for multi-disciplinary input.
  • Human resources likely to have greater impact on
    outcome than Technology

9
Needs and Justification
  • Within adult medicine rates of cancer are
    increasing (even when standardized for age).
  • Cancer is likely to overtake heart disease as the
    1 cause of death in adults, sometime this
    decade.

10
Access to Drugs
  • Major issue in the developing world.
  • Only 20 of the worlds drugs consumed in the
    developing world. (WHO, World Bank, UNESCO)
  • Most drugs are imported (10-20x local cost)
  • Quality of local products sometimes suspect.
  • Rationing of drugs sometimes necessary.

11
Clinical Pharmacy The Garrahan Experience
  • Need for pharmacist participation in patient care
    recognized by pediatric oncologists.
  • Training program established to prepare
    chemotherapy, unit dose antibiotics. Savings on
    drug expenditures considerable, re-invested in
    further pharmacy initiatives.
  • Anti-emetic protocols.
  • Febrile neutropenia protocol.
  • Clinical pharmacokinetics research.

12
Proposed Clinical Pharmacy Program
  • 1 year program based at Juan P Garrahan
    Childrens Hospital, Buenos Aires (Spanish) and
    Centro Infantil de Investigacoes Hematologicas
    Dr. Domingo A Boldrine (Portuguese).
  • Core Didactic Components
  • Drug Literature Evaluation
  • Pathophysiology of Pediatric Malignant Disease
  • Applied Pharmacotherapy
  • Hands on Patient Care.

13
Proposed Clinical Pharmacy Program (2)
  • Intake of 3-5 trainees annually for 2 years.
  • Trainees buddied with junior physician trainee
    in Pediatric Hematology/Oncology.
  • Evaluation/External Review at end of 1st year.
  • Trainees returning to home countries, serve as
    mentors/resource for further trainees.
  • Alternatives (correspondence, Internet) to
    resident training will be explored for
    subsequent years.

14
Is it worth it?
  • No data from developing countries.
  • Data on pharmacist impact in 1st world countries
  • Shorter hospital stay.
  • Fewer adverse drug reactions.
  • Fewer blood tests ordered to monitor
    pharmacotherapy.
  • Positive impact on physician prescribing.
  • Lower drug costs.

15
Opportunities for SOBRAFO
  • Standards of Practice
  • Minimum standards (Safe Handling, Labeling, Dose
    Check/adjustment, Documentation)
  • Realistic goals for the future with realistic
    timelines
  • Formulary Development
  • Drugs which every patient with cancer should have
    access to. (Cytotoxics, Antibiotics, Analgesics
    etc.)
  • Guidelines
  • Antibiotics, Antiemetics, Nutrition Support

16
Opportunities for SOBRAFO
  • ISOPP
  • Training programs for pharmacists in developing
    countries a major goal for ISOPP
  • Chapter Status
  • International Pharmacy Federation

17
(No Transcript)
18
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com